Aspirin and colon cancer--targeting prevention? [N Engl J Med. 2007] - PubMed

loading

Aspirin and the prevention of colorectal cancer. [N Engl J Med. 2003]
Aspirin and the prevention of colorectal cancer.
Berman KS. N Engl J Med. 2003 Jun 12; 348(24):2466-7; author reply 2466-7.
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. [N Engl J Med. 2007]
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.
Chan AT, Ogino S, Fuchs CS. N Engl J Med. 2007 May 24; 356(21):2131-42.
Review Aspirin use and potential mechanisms for colorectal cancer prevention. [J Clin Invest. 1997]
Review Aspirin use and potential mechanisms for colorectal cancer prevention.
Williams CS, Smalley W, DuBois RN. J Clin Invest. 1997 Sep 15; 100(6):1325-9.
Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs. [Dig Liver Dis. 2000]
Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.
Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Drozdowicz D, Kwiecień S, Pajdo R, Ptak A, Pawlik M, Hahn E. Dig Liver Dis. 2000 Oct; 32(7):583-94.
Review Cyclooxygenase inhibitors: drugs for cancer prevention. [Curr Opin Pharmacol. 2003]
Review Cyclooxygenase inhibitors: drugs for cancer prevention.
Shiff SJ, Shivaprasad P, Santini DL. Curr Opin Pharmacol. 2003 Aug; 3(4):352-61.

Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility. [PLoS One. 2013]
Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility.
Thompson CL, Fink SP, Lutterbaugh JD, Elston RC, Veigl ML, Markowitz SD, Li L. PLoS One. 2013; 8(5):e64122. Epub 2013 May 22.
Endomicroscopic Imaging of COX-2 Activity in Murine Sporadic and Colitis-Associated Colorectal Cancer. [Diagn Ther Endosc. 2013]
Endomicroscopic Imaging of COX-2 Activity in Murine Sporadic and Colitis-Associated Colorectal Cancer.
Foersch S, Neufert C, Neurath MF, Waldner MJ. Diagn Ther Endosc. 2013; 2013:250641. Epub 2013 Jan 15.
Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study. [Lipids Health Dis. 2011]
Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study.
Kakutani S, Ishikura Y, Tateishi N, Horikawa C, Tokuda H, Kontani M, Kawashima H, Sakakibara Y, Kiso Y, Shibata H, et al. Lipids Health Dis. 2011 Dec 22; 10:241. Epub 2011 Dec 22.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Aspirin and colon cancer--targeting prevention?
Aspirin and colon cancer--targeting prevention?
N Engl J Med. 2007 May 24 ;356(21):2195-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed